Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

16

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

Tags:

Previous Article

Defining microglial-synapse interactions

Clinical sequelae of gut microbiome development and disruption in hospitalized p...

Related Posts

The 24-hour molecular landscape after exercise in humans reveals MYC is sufficient for muscle growth

The 24-hour molecular landscape after exercise in human...

32

Salmonella re-engineers the intestinal environment to break colonization resistance in the presence of a compositionally intact microbiota

Salmonella re-engineers the intestinal environment to b...

25

A microRNA diagnostic biomarker for amyotrophic lateral sclerosis

A microRNA diagnostic biomarker for amyotrophic lateral...

20